Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incannex Healthcare (IXHL) Current Deferred Revenue: 2024-2025

Historic Current Deferred Revenue for Incannex Healthcare (IXHL) over the last 2 years, with Jun 2025 value amounting to $30,000.

  • Incannex Healthcare's Current Deferred Revenue fell 49.15% to $30,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $30,000, marking a year-over-year decrease of 49.15%. This contributed to the annual value of $30,000 for FY2025, which is 64.71% down from last year.
  • Latest data reveals that Incannex Healthcare reported Current Deferred Revenue of $30,000 as of FY2025, which was down 64.71% from $85,000 recorded in FY2024.
  • In the past 5 years, Incannex Healthcare's Current Deferred Revenue ranged from a high of $85,000 in FY2024 and a low of $30,000 during FY2025.
  • Over the past 2 years, Incannex Healthcare's median Current Deferred Revenue value was $57,500 (recorded in 2024), while the average stood at $57,500.
  • Data for Incannex Healthcare's Current Deferred Revenue shows a maximum YoY plummeted of 64.71% (in 2025) over the last 5 years.
  • Yearly analysis of 2 years shows Incannex Healthcare's Current Deferred Revenue stood at $85,000 in 2024, then plummeted by 64.71% to $30,000 in 2025.